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Cartilage defects pose a significant clinical challenge as they can lead to joint pain, swelling
and stiffness, which reduces mobility and function thereby significantly affecting the quality
of life of patients. More than 250,000 cartilage repair surgeries are performed in the
United States every year. The current gold standard is the treatment of focal cartilage
defects and bone damage with nonflexible metal or plastic prosthetics. However, these
prosthetics are often made from hard and stiff materials that limits mobility and flexibility,
and results in leaching of metal particles into the body, degeneration of adjacent soft bone
tissues and possible failure of the implant with time. As a result, the patients may require
revision surgeries to replace the worn implants or adjacent vertebrae. More recently,
autograft – and allograft-based repair strategies have been studied, however these too are
limited by donor site morbidity and the limited availability of tissues for surgery. There has
been increasing interest in the past two decades in the area of cartilage tissue engineering
where methods like 3D bioprinting may be implemented to generate functional constructs
using a combination of cells, growth factors (GF) and biocompatible materials. 3D
bioprinting allows for the modulation of mechanical properties of the developed
constructs to maintain the required flexibility following implantation while also providing
the stiffness needed to support body weight. In this review, we will provide a
comprehensive overview of current advances in 3D bioprinting for cartilage tissue
engineering for knee menisci and intervertebral disc repair. We will also discuss
promising medical-grade materials and techniques that can be used for printing, and
the future outlook of this emerging field.
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INTRODUCTION
Treatment of cartilage injuries presents a significant challenge in modern orthopedics. Damage to the
articular cartilage due to trauma, degenerative diseases or normal wear and tear affects everyone from
children to the elderly. Poorly-healed cartilage defects cause serious and degenerative morbidities like
osteoarthritis, which is the predominant cause of joint pain worldwide, affecting nearly 303 million
people globally (Wei et al., 2021). The limited self-repair capabilities of the cartilage due to absence of
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vascularization, in which nutrients only reach chondrocytes via
diffusion from the surrounding environment, and low
chondrocyte density (comprising 1–5% of total cartilage)
attributed to the high matrix to cell volume ratio, and the lack
of operative and medical therapies that can significantly facilitate
the healing process has led to an urgent need for new and durable
treatments and grafting strategies to regenerate and repair these
defects (Zhang et al., 2009; Akkiraju and Nohe, 2015; Dai and
Gao, 2016).
Metal and plastic prosthetics that can recapitulate the surface
of joints are currently the gold standard in cartilage and bone
replacement. However, these are often rigid, limiting patient
flexibility and mobility. Friction can lead to rapid wear of
these implants, leading to damage and inflammation in
adjacent tissues. Furthermore, the leaching of metal particles
from the implants into the body can lead to adverse effects
including tissue damage and poisoning (Prezyna, 2000;
Sansone, 2013). Although current strategies to repair cartilage
defects exist, including microfracture surgery, autologous
chondrocyte implantation and osteochondral transplantation,
these procedures have drawbacks such as high failure rates
(25–50% within 10 years) and reduced effectiveness among
elderly patients (Lansdown et al., 2018). Furthermore,
autologous chondrocyte transplantation is marred by shortage
of chondrocyte sources, while microfracture surgery is limited by
the development of fibrocartilage instead of natural hyaline
cartilage in the region, which can worsen joint function
(Zhang et al., 2019; Yang et al., 2020a; Wei et al., 2021). Other
methods such as debridement and spongialization have been
hindered by their clinical invasiveness and the high inherent risk
of developing osteoarthritis (Zhang et al., 2019).
As an alternative to existing strategies, cartilage tissue
engineering is being increasingly explored as a method of
fabricating functional constructs that can facilitate the
regeneration of joint cartilage. Among the many strategies
under consideration, 3D bioprinting has emerged as a
promising method that allows precise control over the
properties of the construct including shape, architecture,
mechanical strength and placement of cells and bioactive cues,
to mimic native cartilage. In this review, we will explore in detail
current technologies being developed for the repair of joint
cartilage as well as 3D printing strategies and materials being
used to improve the properties and functionality of 3D bioprinted
constructs for the development of functional and durable
implants. In particular, we will focus on high-risk, high-load
bearing and motion-critical cartilage: namely, intervertebral discs
and knee menisci, for which current treatment options (e.g.,
implants) do not offer satisfactory biological functionality.
BIOMECHANICS OF JOINT CARTILAGE
In the human body, the three main types of cartilage produced
include hyaline cartilage, elastic cartilage, and fibrocartilage.
Hyaline cartilage, the most common cartilage found in the
body, functions to provide lubrication and load-bearing
support for the articulating surfaces of bones in synovial
joints, essential for joint movement, in addition to playing a
key role in skeletal growth and development (Krishnan, 2018).
Hyaline cartilage is comprised primarily of different types of
collagen, as well as proteoglycans such as aggrecan, which
provides compressive strength and load-bearing support for
tissues due to intermolecular repulsive interactions (Ng et al.,
2003). Similar to hyaline cartilage, elastic cartilage is comprised
mainly of collagen (type II) and proteoglycans. However elastic
cartilage, which can be found in the ear and larynx also contains
elastin fibers, allowing for increased flexibility while maintaining
structural support (Chizhik et al., 2010). Knee menisci and
intervertebral discs (IVDs) are comprised predominately of
fibrocartilage, which exhibits high tensile strength due to the
presence of thick, bundled, and highly ordered collagen (type I)
fibers (Murphy et al., 2015).
Knee Menisci
The menisci are critical for maintaining the health and
performance of the knee joint, providing nutrition, lubrication,
shock absorption, load distribution, and stability of the joint (Fox
et al., 2012; Kester et al., 2021). The semicircular medial- and
circular lateral menisci are fibrocartilaginous wedges that are
attached to the femur via multiple ligaments, as shown in
Figure 1B. The menisci are concave at the femoral surface for
articulation with the condyles and flat on the tibial surface to
connect with the plateau. The outer border is thick and vascular
allowing for firm attachment to the joint capsule, while the inner
border is thin and avascular, allowing for correct orientation
within the joint. The fibrochondrocytes (meniscal cells) maintain
the dense extracellular matrix (ECM) and synthesize the collagen,
FIGURE 1 | Anatomical composition of the (A) human knee (including
menisci) and (B) human intervertebral disc (IVD). Figure 1A reprinted with
minor alterations from (Guo et al., 2015) under Creative Commons Public
Domain Dedication waiver (creativecommons.org/publicdomain/zero/
1.0).
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proteoglycans, and other proteins embedded within (Makris
et al., 2011). Tissue fluid comprises 65–70% of the total weight
of menisci as most of the water is sequestered within
proteoglycans (Herwig et al., 1984). The orientation of the
collagen bundles in the center third region are primarily
radially oriented suggesting that they function in compression,
while those in the outer two-thirds are circumferentially oriented
suggesting a tensile function (McDermott et al., 2008). In
contrast, the collagen bundles are randomly oriented in the
surface layer suggesting they function to decrease friction
(McDermott et al., 2008).
Material properties of the shaped human meniscus is
challenging due to the complexity of the structure. Three
regions (anterior, middle, posterior) of fresh-frozen human
meniscus were tested in compression at four strain rates (3, 6,
9, and 12%) at a physiologically relevant walking strain rate of
32%−s (Chia and Hull, 2008). Young’s Modulus increased with
greater strain and was higher in the anterior region (1,048 kPa at
12%) than the posterior region (329 kPa at 12% strain), which is
8x larger than at physiological equilibrium (Chia and Hull, 2008).
Stiffness in the circumferential direction is greater than that in the
axial and radial direction, which are similar, while thickness
varies inversely with modulus (Lechner et al., 2000; Chia and
Hull, 2008; Norberg et al., 2021). Meniscal biomechanics show
that the lateral meniscus demonstrates greater mobility than the
medial meniscus as the lateral meniscus has 9–11 mm of
anteroposterior displacement and 11.2 mm of mediolateral
displacement, while the medial meniscus exhibits only 2–3 mm
of anteroposterior displacement and 5.1 mm of mediolateral
displacement (Thompson et al., 1991).
Intervertebral Discs
The repair and regeneration of the cartilage of the human spine,
which functions as the body’s central support system and key to
movement, has been the subject of intensive research and the
results have been extensively described and summarized (Panjabi
and White, 1980; Oxland, 2016). The human IVD functions to
give a bipedal upright human spine motion, stability, and
durability. The human IVD, shown in Figure 1A, consists of
three components, including a multilayered outer ring of elastic
collagen tissue fibers [annulus fibrosus (AF)], which is oriented at
alternating angles (50–60 + degrees) that provides stability in
torsion, compression and tension (Panjabi and White, 1980;
Oxland, 2016). The concentric rings do not fully form
complete circles in the posterior and posterolateral regions,
which make these areas susceptible to herniation, fissures and
failure (Panjabi and White, 1980; Oxland, 2016). The gelatinous
elastic center (nucleus pulposus (NuP)) transmits stress and
weight between vertebrae (Panjabi and White, 1980; Oxland,
2016). The NuP has semi-solid-like properties and therefore
expands outward when compressed, which also expands the
elastic fibers of the AF. This structure is connected to adjacent
vertebrae by the Sharpey’s fibers of the relatively flat cartilaginous
end plates (CEP) of the vertebral bodies (Panjabi and White,
1980; Oxland, 2016). These three components, the AF, the NuP
and the CEP are intimately integrated to function as a unit with
the vertebrae above and below forming a spinal unit or motion
unit that allows combinations of flexion, extension, lateral
bending, and rotation of the spine at varying degrees
depending on the location in the spine.
Mechanical properties of the human IVD are the topic of
interest in many studies, and for good reason, given the
debilitating results of their malfunction/degeneration (Markolf,
1974; Yoganandan et al., 1989; Iida et al., 2002; Stemper, 2010).
While it had been believed that the NuP is mainly responsible for
the elastic properties of the IVD, all components contribute
significantly (Markolf, 1974). The compressive stiffness (E
modulus: 19.5 ± 4.1 MPa in 28 ± 8 year old persons and
10.6 ± 3.4 MPa in 70 ± 7 year old persons) of the healthy IVD
is 6–7 times higher than the tensile stiffness (E modulus: 2.9 ±
0.8 MPa in 28 ± 8 year old persons and 1.7 ± 1 MPa in 70 ±
7 year old persons 3.3 ± 2.1 MPa) (Iida et al., 2002; Stemper,
2010). Stiffness of the spine can vary depending on the spinal
region (Shea et al., 1991). The loading of the IVD measured
during normal activities was 0.1–0.5 MPa and increased up to
2.3 MPa during lifting 20 kg weight (Wilke et al., 1999). Studies
on sheep IVDs showed increased stiffness of IVD after cycled
loading, which fully recovered after a period of unloading
(Johannessen et al., 2004).
CURRENT TECHNOLOGIES FOR JOINT
CARTILAGE REPAIR
Damage to- or degeneration of joint cartilage can lead to the
development of debilitating arthritis, thereby impairing joint
function (Abrams et al., 2013). In response to this, the
number of research papers published on cartilage repair have
nearly doubled in recent years, with the main focus being on
replacement or regeneration of the knee meniscus and
replacement of intervertebral discs (Abrams et al., 2013).
Knee Cartilage
The critical role of the meniscus in knee biomechanics and joint
health is well known (Kester et al., 2021). Preservation of knee
meniscus by repair, allograft transplantation and partial
meniscectomy in the US is the current standard of care
(Abrams et al., 2013; Kester et al., 2021). Over a 7 year period,
the number of meniscectomies increased by 14% while the
number of meniscus repairs increased by 100% (Abrams et al.,
2013). Failure rates for meniscal repair were relatively low: 12%
up to 1 year, 15% up to 2–3 years, and 16.5–19% up to 4–6 years
post-repair (Ow, 2021). Meniscal repairs typically result in more
revision surgeries, but remain a more effective long-term
treatment than meniscectomies. Accordingly, while total
meniscectomy can provide short-term relief and improve
function, there remains a high risk of developing osteoarthritis
over the long term (Abrams et al., 2013; Kester et al., 2021;
Veronesi et al., 2021). The chondroprotective effects as well as the
stabilizing and load-distributing function of the meniscus are
thought to have led to the increase in the choice of repair over
removal (Abrams et al., 2013). Advances in arthroscopic
techniques, instrumentation, and postoperative care have also
likely contributed to the rise in repairs (Abrams et al., 2013).
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Allograft transplants and implants show promise for restoring
meniscal function. Transplant of meniscal allograft tissue to
replace removed meniscus has shown encouraging results,
however the availability of such tissue is limited, and can be
subject to strict regulation in some countries (Veronesi et al.,
2021). Meniscal scaffolds can stimulate repair and even
regeneration of meniscal tissue, and is therefore an area of
increasing research interest (Veronesi et al., 2021). Two
acellular scaffolds are currently in clinical use, including Actifit
(polyurethane-based) and collagen meniscus implant (CMI)
(collagen-based). Both have demonstrated promising results in
terms of moderate-to significant pain relief (measured on
multiple scales) and improved movement/joint functionality
over the mid-to long term (study durations lasting <10 years
post-implantation) although regeneration is limited (Veronesi
et al., 2021). These scaffolds remained biocompatible, while
promoting limited meniscal healing, and therefore
chondroprotection, which in turn decreased patient pain
(Veronesi et al., 2021). Despite these early achievements, there
has been a distinct lack of new meniscal implants (of any kind)
approved for clinical use over the last decade.
Intervertebral Discs
Total disc replacement (TDR) and fusion of the spinal column
have been used to treat degenerative disc disease for several years
(Punt et al., 2008). Despite rising rates of fusion, procedures still
come with concerns regarding failure to achieve a solid fusion
mass (pseudarthrosis) and adjacent segment degeneration
(Salzmann et al., 2017). TDR implantation rates have
remained steady in the U.S. over the last decade, possibly due
to issues with correct sizing and placement of the implant, the
difficult nature of the surgery, lack of device selection, or fear of
postoperative complications (Punt et al., 2008; Salzmann et al.,
2017). The only TDR implants currently approved by the Food
and Drug Administration (FDA) are metal based (U.S. Food and
Drug Administration, 2020). THE PRODISC L TOTAL DISC
REPLACEMENT -P050010/S020; U.S Food and Drug
Administration (2015) activL® Artificial DiscPatient
Information -P120024. A006; Geisler, 2006).
Damaged IVDs of the spine can be fixed by replacing the disc
with non-flexible material and then fusing the adjacent vertebrae
using titanium plates, which results in reduced joint mobility
(Rajaee et al., 2012). The number of patients having spinal fusion
surgery increased from 203,053 to 442,776 annually from 1998 to
2014 (Sheikh et al., 2020). Despite providing temporary relief,
adjacent spinal discs are often damaged due to increased stresses
imposed on them as a result of lack of flexibility of fused vertebrae
(Rajaee et al., 2012).
Artificial disc replacement has recently emerged as an
alternative to fusion due to safer surgical procedures and
better preservation of joint mobility (Park, 2015; Salzmann
et al., 2017). However, total disc replacement (TDR) rates for
intervertebral discs are low due to strict regulations for implant
surgeries, demanding surgical techniques, low implant selection,
and complications, requiring further surgery (Salzmann et al.,
2017). Current TDR devices are composed of metal alloy plates
sandwiching a plastic core, or a titanium mesh cage for bone
infiltration that replaces the intervertebral disc, both of which can
leach metal particles into the body and cause degeneration of
relatively softer adjacent vertebrae and facets (FDA clears “first
ever” 3D printed spine implant to treat of multiple injuries, 2018;
Salzmann et al., 2017). One solution to preventing the
development of adjacent segment disease is to preserve native
biomechanics by replacing fusion techniques with motion sparing
artificial discs. A new artificial cervical (SECURE-C TDR) metal
disc has recently been developed to maintain physiologic motion,
thereby reducing the risk of adjacent segment degeneration
(McConnll, 2016).
There are currently three implants approved by the FDA for
total disc replacement in the spine, including the Charité III
Artificial Disc (DePuy Spine Inc., Raynham, MA), ProDisc-L
(Synthes Spine, Paoli, PA) and the activL Artificial Disc (Aesculap
Implant Systems, LLC), which are shown in Figures 2A,B,
respectively (Salzmann et al., 2017). The Charité Artificial Disc
consists of an ultra-high molecular weight polyethylene core that
slides between the metallic alloy (containing cobalt, chromium,
and molybdenum) endplates, with anchoring teeth on both top
and bottom for attachment (Putzier et al., 2006). ProDisc-L
consists of two metallic (containing cobalt and chromium)
endplates and a plastic (ultra-high molecular weight
polyethylene) ball-and-socket style center, with corrugated
metal teeth on the top and bottom plates for attachment (U.S.
Food and Drug Administration, 2020). THE PRODISC L TOTAL
DISC REPLACEMENT-P050010/S020). The activL Artificial
Disc is made of two cobalt-chromium alloy endplates and one
polyethylene inlay. The plastic center is attached to the bottom
endplate, and the top plate is designed to move over the center,
allowing motion in all directions (U.S Food and Drug
Administration, 2015) activL® Artificial DiscPatient
Information-P120024. A006; Miller et al., 2016). There are
three anchoring spikes on each of the top and bottom end
plates. Additional materials used in intervertebral disc
implants may include other cobalt-chromium alloys, stainless
steel, titanium alloys, polyurethanes, and titanium alloy-ceramic
composites (Pham et al., 2015).
Despite the successful use of metallic implants, there are still
biomechanical-and toxicity concerns regarding wear debris
(Salzmann et al., 2017). Wear reduces the lifetime of a
prosthetic and leaves potentially harmful debris, potentially
requiring the need for additional surgeries (Shankar and
Kesavan, 2016). Several researchers have reported elevated
levels of metal ions in the blood and urine of patients with
metal-on-metal devices (Jacobs et al., 1996; Massè et al., 2003;
Savarino et al., 2003). Postmortem studies have also found
significant metal ion bioaccumulation in the liver, kidney,
spleen, heart, and lymphatics of those patients outfitted with
metallic implants (Urban et al., 2000). This metallosis is suspected
to be an underreported or underdiagnosed issue, and has been
shown to result in chronic inflammation, causing a host of
unpleasant symptoms (nausea, cognitive impairment,
hematological aberrations etc.) and more serious complications
such as osteolysis or pseudotumors (Vaz et al., 2019). Further,
more systemic and long-term impacts of circulating or
accumulated metal ions is not completely understood, making
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their avoidance desirable. The AcroFlex lumbar disc replacement
is one example of a metallic implant that was discontinued after
poor clinical outcomes (mechanical failures, osteolysis, etc.)
(Germain and Tumialan, 2012; Meir et al., 2013). There is a
need to fill this gap in available synthetic and non-metallic
implants that exhibit some degree of flexibility and can
conserve motion while providing sufficient load-bearing support.
Overcoming Wear: The Evolution of
Traditional Cartilage Repair
Some attempts have been made to improve upon the wear-
resistance of materials used for the repair of cartilage injury.
These encompass various nanocomposites, metal-on-polymer
arrangements, ceramics and their composites, as well as woven
materials, all with the goal of increasing wear resistance and
decreasing wear debris and their physiological effects. One such
example is oxidized zirconium (oxinium, possessing ceramic-like
properties) with cross-linked polyethylene. Originally utilized for
hip replacements, this technology has recently found its way to
knee replacements, wherein the ends of the femur and tibia are
capped with oxinium, with a polyethylene-based disc acting as the
meniscus (Bhandari et al., 2012). The expected end-result is less
metal-on-metal friction and wear. While touted as a replacement
to older cobalt-containing setups, long-term studies have shown
almost comparable (low) rates of wear, and no reduction in
revision rates (Kim et al., 2012; Zou et al., 2020). Polymer
through-wear followed by wear debris release has also been
documented in some patients (Frye et al., 2021). Moreover,
this technology involves surgery of even greater invasiveness
owing to the complicated capping process. Oxinium debris
has, however, shown lower inflammation elicitation than older
cobalt counterparts (Rose et al., 2012). Other ceramics have also
been used in this area, although mostly for hip arthroplasty.
Ceramics have a low coefficient of friction and excellent wear
resistance but are generally poor in terms of fracture-resistance
owing to their brittleness, and sub-optimal load-bearing and
flexibility capabilities (Yup Lee and Kim, 2010). Frequent
squeaking of the joints during movement is a common patient
complaint when using ceramic-on-ceramic joint replacements
(Jarrett et al., 2009). A quite recent development has been the
exploration of woven materials: being made of polymeric or
hybrid polymer-natural fiber composites, these would have less
harmful wear debris. Rodts et al. presented some interesting early
work in this area, using laser welding to impart high wear-
resistance to their constructs, but–focusing entirely on wear
resistance–did not provide any notable data with regard to
mechanical properties or in vivo performance (Rodts et al.,
2019). With no load-bearing substructure, it is difficult to
envision these being applied successfully in cartilage or other
constructs by themselves.
3D PRINTING FOR CARTILAGE
ENGINEERING
As a result of the limitations of current treatment options, there
has been increased attention focused on cartilage and tissue
engineering to overcome these limitations and facilitate joint
regeneration. 3D printing is a popular type of additive
manufacturing (AM) technology in which constructs are built
in a layer-by-layer fashion, allowing for the design and
production of patient-centric implants. 3D printing technology
can be used to produce patient-personalized constructs (e.g.,
IVD’s) in a time- and cost-effective manner, allowing for
greater flexibility in terms of material selection, typically
resulting in the production of more biocompatible constructs
compared to metallic implants produced via traditional
manufacturing methods (Lim et al., 2019). Various computer
aided design (CAD) programs can be used to construct digital
models, typically based on patient centric data obtained via
computer tomography (CT) and magnetic resonance imaging
(MRI) scans. These models can then be imported into software
capable of editing and segmenting files, retaining only particular
regions of interest. Lastly, files can be uploaded into a slicing
software, where printing parameters such as number of layers and
layer height are determined. This process can greatly improve the
accuracy and translational potential of printed constructs.
Bioprinting is a subtype of 3D printing, in which the materials
used in the 3D printing process contain cells and other
biomaterials to produce a final construct. It is an emerging
manufacturing technique used to develop tissue engineered
constructs with very precise size and shape attributes, while
maintaining excellent cell adhesion and proliferation abilities.
FIGURE 2 | Three intervertebral disc implants currently approved for use by the FDA including: (A) Charité III disc replacement (Depuy Spine) and (B) Prodisc-L
(Centinel Spine) and (C) ActivL
®
artificial disc (Aesculap Implant Systems). Figures 2A,B reprinted with no alterations from (Kaner and Ozer, 2013) under Creative
Commons Public Domain Dedication waiver (creativecommons.org/publicdomain/zero/1.0). Figure 2C (Aesculap’s activL® Artificial Disc product image) used with
permission from Aesculap Implant Systems, LLC, Center Valley, PA.
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Conventionally used metallic implants for meniscus and IVD
repair fail to recapitulate the complex biological environment and
mechanical structure of native tissue, while also presenting
potential toxicity concerns via metal particle leaching in the
body (Tavakoli et al., 2020). Overall biocompatibility of
printed implants is intimately linked to the materials used in
the printing process, which has been the focus of many review
papers in recent years (Tappa and Jammalamadaka, 2018). In
addition, traditional cartilage tissue engineering approaches
result in scaffolds with a homogeneous distribution of
chondrocytes or cartilage progenitor cells, and fail to
recapitulate the complexity of native cartilage tissue (Daly and
Kelly, 2019). Through meticulous material and printing
parameter optimization, bioprinting allows for the fabrication
of printed constructs demonstrating precise spatial and temporal
control on the placement of cells and other bioactive substances
(such as growth factors) while exhibiting similar chemical and
mechanical properties as native tissue to better guide tissue
formation, ideal for cartilage and tissue regeneration
applications (Buj-Corral et al., 2018).
To produce 3D printed implants for cartilage repair, available
3D bioprinting techniques include inkjet bioprinting, extrusion-
based bioprinting, vat polymerization (VP), and laser assisted
bioprinting (LAB). Currently, inkjet and extrusion-based printers
remain the most common types of printers used for cartilage
tissue engineering applications.
Inkjet Bioprinting
Inkjet printing is a type of powder bed printing technology in
which binder droplets, containing cells and other biomaterials
(such as growth factors) are dispensed through overhead
printheads and deposited onto a substrate, as shown in
Figure 3A (Shirazi et al., 2015). Inkjet printing is
advantageous compared to other traditional bioprinting
techniques due to the capability to produce constructs in a
cost-effective and high throughput manner (Li et al., 2020).
For example, Daly et al. used an inkjet printing approach to
produce stratified cartilage tissue by developing a bioink
consisting of mesenchymal stem cells (MSC), chondrocytes
and either pluronic or gelatin methacrylate (GelMA) and
injecting this bioink into polymeric microchambers to guide
cell growth and more representatively mimic native cartilage
tissue (Daly and Kelly, 2019). However, the droplet ejection
process, which can be achieved either via thermal or
piezoelectric actuation, can be detrimental to maintaining
adequate cell viability in printed constructs due to incurred
shear and thermal stresses leading to cell death (Li et al.,
2016). In addition, depending on bioink viscosity, nozzle
clogging can occur, preventing a smooth print from being
achieved. Cui et al. (2014) modified an HP Deskjet 500
thermal inkjet printer, allowing it to print a
photopolymerizable bioink containing human chondrocytes
suspended in poly (ethylene glycol) diacrylate (PEGDA),
suitable for cartilage tissue engineering applications.
Extrusion-Based Bioprinting
Traditionally, extrusion-based 3D printing, including fused
deposition modeling (FDM) is accomplished by feeding a
solid, thermoplastic filament through a high temperature
nozzle, in which the material is then continuously extruded
and deposited onto a lower temperature build plate,
facilitating material solidification (Long et al., 2016). Despite
FIGURE 3 | Schematic diagram of the most common 3D bioprinting techniques in cartilage tissue engineering, including (A) inkjet bioprinting, (B) extrusion-based
bioprinting, (C) vat polymerization, and (D) laser-assisted bioprinting.
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allowing for rapid and efficient prototyping, FDM is not suitable
for thermolabile components, including cell and proteins which
can degrade under high temperatures. In addition, this method is
only suitable for printing using solid filaments and is not capable
of printing liquid cell suspensions. Thus, commercial bioprinters
have been developed in recent years to overcome these obstacles.
Extrusion-based commercial bioprinters rely on either
pneumatic, piston, or screw-driven configurations to achieve
continuous bioink extrusion, as shown in Figure 3B. In
pneumatic-based extrusion, air pressure provides the main
driving force for bioink dispensing, whereas in piston and
screw-driven extrusion, vertical rotational forces are exerted
on the bioink resulting in extrusion (Derakhshanfar et al.,
2018). It is important to note that certain configurations, such
as screw-driven extrusion, may negatively impact cell viability
due to large pressure drops that occur along the nozzle (Ozbolat
and Hospodiuk, 2016). Commercial bioprinters are typically
considerably more expensive than traditional 3D printers,
which may present a significant barrier to entry for some
researchers interested in bioprinting, although more cost-
effective options have become available. Thus, some
researchers have modified existing extrusion-based printers,
enabling them to print liquid bioinks. For example, Gantumur
et al. (2020) developed an alginate-based bioink containing
fibroblast cells that can be printed at room temperature using
a modified Prusi i3 3D printer via an enzyme-mediated
hydrogelation method. Cell viability was similar in printed and
non-printed hydrogels (54.1% in printed vs 50.4% in non-printed
after 1 day of culture), showing that this printing process did not
adversely impact the fate of the cells and demonstrating the
feasibility of this technique for bioprinting applications.
Vat Polymerization Bioprinting
Unlike extrusion-based printing, VP techniques rely on the layer-
by-layer solidification of liquid photopolymerizable resin,
containing photopolymerizable monomer(s) and
photoinitiator(s), as shown in Figure 3C. A build plate moves
along the z-axis inside a resin-containing vat. Upon exposure to a
specific wavelength of light (dependent on resin components), the
resin polymerizes and solidifies (Martinez et al., 2017). Layer
adherence/formation is facilitated by unreacted monomers in the
previous layer polymerizing upon light exposure.
Stereolithography (SLA) and digital light processing (DLP) are
the two main types of VP techniques, with the former using a
laser beam and the latter using UV light from a projector to cure
the resin. VP printing can overcome limitations inherent to other
printing techniques, such as avoiding physical stresses imposed
on bioinks (e.g., extrusion-based printing), which can ultimately
lead to improved cell viability while maintaining high print
resolution of final constructs (Kadry et al., 2019). Grogan et al.
(2020) developed scaffold-free cartilage tissue constructs via a
Regenova bioprinter in which microspheroids, held in place by a
microneedle array, eventually fuse together to form neotissues. Li
et al. (2017) combined 3D scanning technology with VP-based
3D printing (modified Bio-Architect, Regenovo) to more
accurately replicate bone and cartilage defects, using either an
alginate- or a hyaluronic acid (HA) based photopolymerizable
hydrogel platform. Despite the advantages, concerns regarding
photopolymer biocompatibility remains an issue, as unreacted
resin components can present cytotoxicity issues at certain
concentrations (Sabnis, 2010; Choi and Cha, 2019; Nguyen
et al., 2019).
Laser Assisted Bioprinting
LAB is a technique in which a pulsed laser source (UV or near-
UV wavelengths) is focused through a donor slide onto an
absorbing layer, causing immediate vaporization and resulting
in an area of high vapor pressure, facilitating droplet formation of
the bioink layer underneath, which then deposits onto a substrate
below (Figure 3D; Li et al., 2016). Printing via LAB circumvents
issues typically encountered in traditional bioprinting processes,
such as thermal and shear stresses that often lead to lowered cell
viability in printed constructs. In addition, high resolution
constructs and enhanced cellular organization can be achieved
via LAB through optimization of ink droplet characteristics, such
as ink viscosity and laser energy (Guillotin et al., 2013). However,
LAB is a relatively time-consuming and expensive bioprinting
method compared to conventional bioprinting techniques.
Keriquel et al. (2017) developed a clinically feasible in situ
forming collagen-nano hydroxyapatite (HAp) composite
bioink containing mesenchymal stromal cells suitable for bone
defect repair applications using a LAB technique. The LAB setup
consisted of a near-infrared pulsed laser beam coupled to a
scanning mirror, which focused the laser beam onto the
absorbing layer (containing a thin layer of bioink), leading to
droplet generation and deposition.
BIOINKS
Materials used to successfully produce bioprinted knee menisci
and IVD’s need to exhibit certain characteristics, such as
biocompatibility to minimize immune response in the body;
similar mechanical properties as native cartilage tissue to
provide support to high load bearing regions such as in
meniscus repair; and capability of promoting cell adhesion and
proliferation, leading to cartilage tissue regeneration (Ahmed
et al., 2019). Bioink components such as transforming growth
factor beta-3 (TGF-β3) and bone morphogenetic protein-6
(BMP-6), can bind to cellular receptors, leading to cell
differentiation and proliferation (Roseti et al., 2018). Daly
et al. (2016) investigated properties of extrusion-based printing
and the in vitro cartilage development achievable via the use of
common bioinks, containing MSC and TGF-β3, including
agarose, alginate, GelMA and polyethylene glycol methacrylate
(PEGMA, BioINK™). Results demonstrated that agarose and
alginate (which lack cell binding motifs) better supported the
development of hyaline-like cartilage, while GelMA and
PEGMA-based bioinks (which exhibit natural cell binding
motifs and can promote cell spreading) were more suitable for
fibrocartilaginous tissue development, illustrating that bioink
composition plays a key role in determining cell phenotype. In
addition, incorporation of polycaprolactone (PCL) fibers allowed
for tailored mechanical properties to make printed constructs
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more suitable for load-bearing applications (e.g., articular
cartilage designed for joint movement) and improve their
translational potential. Examples of cartilage tissue constructs
fabricated via different bioprinting techniques with various types
of bioinks are shown in Table 1.
Natural Polymers
Natural polymers with excellent biocompatibility and biological
activity are an ideal class (relative to synthetic polymers) of
materials suitable for use in bioinks, as they are capable of
supporting cell attachment and differentiation (Liu et al.,
2018). Despite the inherent advantages, natural polymers
typically exhibit weaker mechanical properties than synthetic
polymers, which can lead to poor printability and hinder in
vivo performance. Constructs produced using solely natural
polymers are typically more prone to failure within the body,
as their mechanical properties are often not sufficient to
withstand forces exerted in vivo. Thus, addition of materials
that exhibit enhanced mechanical properties to form
composites, and optimization of material crosslinking are
strategies that are often used to develop more suitable natural
polymer-based bioinks (Peng et al., 2020).
Alginate is a polysaccharide originally derived from brown
algae and is often used to produce constructs capable of
mimicking ECM structure by crosslinking with calcium ions
(Ca2+). Alginate is a promising bioink material due to its
biocompatibility and rapid gelation process, leading to suitable
printability. Yu et al. (2013) produced tubular channels, designed
to mimic native vasculature, via an extrusion-based printer using
a sodium alginate based bioink containing cartilage progenitor
cells, capable of achieving cell viability up to 89%. To improve
printability and cell proliferation ability of alginate-based bioinks,
composite materials have been developed. For example, Antich
et al. (2020) developed a HA-alginate composite bioink able to
produce chondrocyte-laden constructs that exhibited improved
mechanical properties (e.g., increased viscosity) leading to
enhanced printability, while maintaining impressive cell
viability (>85%) immediately after printing, with similar cell
viability up to 4 weeks later.
HA is a linear polysaccharide and natural glycosaminoglycan
(GAG) that plays numerous roles in the human body, such as
maintaining ECM structure and acting as a signaling molecule
capable of interacting with many cell surface receptors (Dicker,
2014). HA is a biocompatible and biodegradable material and can
be easily chemically modified to alter its biological functions,
therebymaking it an ideal material for cartilage tissue engineering
applications. However, like other natural polymers, HA exhibits
relatively weak mechanical properties, leading to decreased
printability. Ouyang et al. (2016) developed a 3D printable
modified HA-based hydrogel ink, relying on guest-host
supramolecular assembly via adamantane and β-cyclodextrin
coupled to HA, resulting in increased viscosity and storage
modulus values for modified HA hydrogels. In addition,
fibroblast cells were seeded onto printed hydrogels and
displayed adequate cell adhesion, illustrating the potential for
this material to be used for cartilage tissue engineering
applications. Park et al. (2014) developed a bioprinted (in-
house extrusion based printer) multicompartment hydrogel
platform designed to promote osteochondral tissue
regeneration, comprised of a chondrocyte-encapsulated HA
compartment and osteoblast-encapsulated collagen (type I)
compartment, capable of maintaining good cell viability of
both cell types.
Collagen is the most abundant protein in the human body, and
has been used to produce bioinks that effectively mimic the ECM
structure while promoting cell adhesion, proliferation, and
migration (Somaiah et al., 2015). As with other natural
polymers, collagen suffers from relatively weak mechanical
properties. Rhee et al. (2016) developed a bioink consisting of
high concentration (>10 mg/ml) pure collagen containing
meniscal fibrochondrocytes, and demonstrated that fabricated
constructs could not accurately recapitulate the mechanical
properties of native meniscal tissue. Shim et al. (2016)
developed a multilayered construct using a bioink comprised
TABLE 1 | Examples of cartilage tissue constructs printed using different bioprinting techniques.
Type of bioprinting Cell type Bioink materials Cell viability Ref
Inkjet Chondro-cytes PEGDA 90% Cui et al. (2014)
MSC PEGDMA >80% Gao et al. (2015a)
GelMA
Extrusion-based CPC Alginate Up to 89% Yu et al. (2013)
Chondro-cytes HA alginate >85% Antich et al. (2020)
PLA scaffold
Chondro-cytes Alginate 85–97% Kundu, (2013)
TGFβ
PCL scaffold
Vat polymerization Chondro-cytes GelMA — Chen et al. (2019)
Decellularized cartilage ECM
Chondro-cytes GelMA Up to 95% Lam et al. (2019)
HAMA
Laser-assisted Mesench-ymal stromal cells Collagen — Keriquel et al. (2017)
Nano-hydroxyapatite
MSC Alginate — Gruene et al. (2010)
CPC, cartilage progenitor cells; ECM, extracellular matrix; GelMA, gelatin methacrylate; HA, hyaluronic acid; HAMA, methacrylated hyaluronic acid; MSC,mesenchymal stem cell; PEGDA,
poly(ethylene glycol) diacrylate; PEGDMA, poly(ethylene glycol) dimethacrylate; PLA, polylactic acid; PCL, polycaprolactone; TGF-β, transforming growth factor-β.
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of modified HA (Cucurbit [6]uril and 1,6-diaminohexane
(DAH)-conjugated HA) and pepsin-treated collagen
(atelocollagen) containing human turbinate-derived
mesenchymal stromal cells as well as additional biomaterials
(e.g., BMP-2 and TGF-β) capable of inducing cartilage
regeneration in an in vivo rabbit model.
Gelatin is a linear peptide produced from the denaturation of
collagen. Gelation can occur via chemical/enzymatic reactions or
physical crosslinking, which requires heating and subsequent
cooling to produce a semi-solid gel (Bello et al., 2020). Gelatin
is an attractive bioink material due to its biocompatibility,
biodegradability, and ease of modification (e.g., GelMA),
allowing for facile crosslinking and enhanced cellular
interactions (Gungor-Ozkerim et al., 2018). However,
crosslinking of pure gelatin can be slow and may result in
printed constructs that are mechanically inferior to native
tissue. To overcome these issues, Singh et al. (2019) developed
a gelatin encapsulated composite bioink containing a silk blend
(Bombyx mori and Philosamia ricini) designed to enhance bioink
mechanical properties, leading to enhanced printing fidelity while
promoting the growth and proliferation of chondrocytes for
cartilage tissues regeneration applications. Bioinks have also
been developed containing modified gelatin, such as GelMA,
in which the degree of methacryloylation and GelMA
concentration have been shown to play a key role in
modulating overall mechanical properties, including viscosity
and stiffness (Leucht et al., 2020).
Other natural polymers, such as silk fibroin and elastin have
recently been used in bioinks to produce more physiologically
relevant IVD components (i.e., annulus fibrosus) (Costa et al.,
2019). Such constructs demonstrate tunable degradation profile
and mechanical properties, while remaining biocompatible. On a
similar note, Tamo et al. developed a 3D printable chitosan-based
hydrogel reinforced with cellulose nanofibers to better address the
needs of developing mechanically demanding tissue repair
strategies, for use in IVD and menisci repair applications,
amongst others (Kamdem Tamo et al., 2021).
Synthetic Polymers
Compared to natural polymers, synthetic polymers such as
polycaprolactone (PCL), polyethylene glycol (PEG), and PEG
derivatives, such as Pluronic, exhibit more suitable mechanical
properties, and are thus better able to withstand the forces exerted
during the bioprinting process (Liu andWang, 2020). In addition,
they can support the development of porous structures and
microchannels, which serve to recapitulate the vasculature of
native tissue. Typically, however, synthetic polymers lack the
biological activity necessary for promoting cell growth and
proliferation and are thus used primarily for their role in
providing structural support for bioinks (Wu et al., 2011).
PCL is a slow-degrading biocompatible polyester that has been
used previously in bone tissue scaffold fabrication, and other
medical products such as suture and bone screws (Chen et al.,
2015; Cho et al., 2019; Dwivedi et al., 2020). PCL is commonly
used in bioprinting applications to enhance the mechanical
properties of printed constructs. Previous studies have
supported this notion, as constructs have been fabricated using
PCL as a scaffold material demonstrating an increase in elastic
moduli that more closely mimic native articular cartilage (Daly
et al., 2016). Kundu (2013) developed a chondrocyte-containing
alginate-based bioink able to be printed onto a PCL scaffold using
an extrusion-based multi-head deposition system for cartilage
tissue engineering. In this study, PCL was used as a support
structure for the cell-laden alginate hydrogel, while facilitating
cartilage tissue regeneration up to 14 days post-implantation, as
demonstrated using a nude mice model.
PEG is a highly tunable, relatively inert synthetic polymer
synthesized via the polymerization of ethylene oxide, that exhibits
favorable mechanical properties suitable for cartilage tissue
applications. Poloxamer, also known as pluronic, is a PEG-
based block copolymer and is also commonly used in bioink
development. PEG-based derivatives are attractive bioink
materials due to their tunable gelation and favorable
mechanical properties, both of which can be modulated by
altering pluronic concentration (Geng et al., 2011). For
instance, Ribeiro et al. (2018) investigated the printability of
PEG/poloxamer-based bioink blends and demonstrated that
bioink mechanical properties could be tuned by changing the
PEG/poloxamer ratio, noticing that as this ratio increased,
mechanical properties (i.e., yield stress, viscosity and storage
modulus) decreased correspondingly. PEG and PEG
derivatives have been combined with other biologically-active
materials to facilitate cell adhesion and proliferation on printed
constructs (Hutson et al., 2011; Rutz, 2015). For example,
Armstrong et al. (2016) developed a pluronic-alginate
composite bioink capable of producing constructs exhibiting a
highly porous structure ideal for cell growth and nutrient
transport, that supported the proliferation and differentiation
of hMSCs over a 5-week period. In addition, photopolymerizable
PEG-based materials, such as PEGMA, PEGDA and
polyethylene-tetracrylate (PEGTA)–which can crosslink via
light irradiation–have been developed and are commonly used
in bioink formulations for their tunable mechanical properties
FIGURE 4 | Schematic diagram of the general structure of human
articular cartilage, shown in the context of the knee. The deep zone contains
hypertrophic chondrocytes interspersed with radially arranged collagen fibers,
progressing to polymorphic chondrocytes and randomly arranged
collagen in the middle layer. The superficial layer closest to the articular surface
contains flattened chondrocytes packed in between horizontally arranged
fibers of collagen.
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and facile crosslinking abilities (Skardal et al., 2010). Gao et al.
(2015b) developed a hMSC-encapsulated photopolymerizable
PEGDMA-peptide bioink demonstrating good printability
capable of producing scaffolds promoting bone-and cartilage
regeneration.
CELL-BASED 3D BIOPRINTING
The earliest record of 3D bioprinting with cells being utilized for
the regeneration or repair of cartilage is provided by the work of
Cui et al. (2012). Fine spatial control and print resolution is highly
useful when one considers the distinct structural zones that exist
within articular cartilage, particularly the stratification by cell
type. Chondrocyte organization, shape and expression patterns
have been observed to vary markedly across three distinct layers:
the superficial-, middle- and deep zones, as shown in Figure 4
(Akkiraju and Nohe, 2015). Alternatives to 3D bioprinting such
as micromolding or other conventional techniques struggle to
recreate these delicate features without significant and
painstaking work, often with no guarantee of success.
Bioprinting can allow cells with pre-induced expression
profiles to be printed in distinct organizational patterns,
densities, and depths, while other techniques with low control
makes achieving local homogeneity in cell distribution a tough
task. Tight spatial control also allows for the use of multiple
polymer or matrix materials in complex patterns to achieve
desired local-or global mechanical characteristics. This cell-
friendly fabrication process allows cells to be seeded earlier on
in the fabrication process, further improving fabrication times
that have already been made shorter by bioprinting’s automated
nature. In all, these serve collectively to produce high quality,
highly biomimetic cartilage structures.
Cell-Based Bioprinting of Knee Cartilage
Articular cartilage of the knee is one of the most commonly
damaged type of cartilage in the human body, as a result of a
variety of factors such as age, physical activity or diseases such as
osteoarthritis, compounded by the joint’s sheer complexity and
load-bearing role (Gracitelli et al., 2015). As a result, most
bioprinted cartilage applications have focused on regenerating
the cartilage of the knee. Given that articular cartilage damage
frequently co-occurs with lesions on the subchondral bone, a
recent paper by Yang et al. (2020b) sought to produce an
integrated, 3D bioprinted construct capable of regenerating
both the damaged cartilage and the bone below it. To this
end, they printed a layered composite consisting of sodium
alginate and gelatin in the “cartilage” layer, and sodium
alginate, gelatin and hydroxyapatite in the “bone” layer (the
latter being an essential component of the bone regeneration
process) with pore sizes of approximately 500 μm (Kattimani
et al., 2016). These inks were seeded with pre-differentiated
osteogenic and chondrogenic bone marrow mesenchymal stem
cells (BMSCs) prior to implantation on rabbit knee lesions for in
vivo studies. The mechanical properties of this construct were
inferior to that of natural cartilage, with a compressive strength of
11 MPa after 6 months post-implantation (30 MPa in natural
cartilage) and a maximum tolerable load of 183 N (480 N in
natural cartilage), which may be attributed to the mechanical
properties of the chosen bioink in this study. Despite this, cell
viability in vitro was sufficiently high (>70% by day 7) and
mechanical properties were significantly better than cell-less
controls. Notably, the complete implants could produce
hyaline-like cartilage with a still-disorganized structure and
delicate links to the surrounding cartilage by 3 months post-
implantation, and by 6 months, was histologically
indistinguishable from the surrounding cartilage, although a
small ‘transition area’ was visible. This stood in contrast to
blank or even cell-less controls where repair either did not
happen or was much slower and did not show the key
integration with the surrounding cartilage or the subchondral
bone. Another research group attempted a similar approach,
printing a HAp-doped gelatin hydrogel (10–50 μm pore size)
with human umbilical cord blood-derived mesenchymal stem
cells (Huang, 2021). The construct was demonstrated to possess a
compressive modulus of approximately 77 kPa, with HAp’s role
in lending compressive strength apparent in the lower
compressive modulus of gelatin-only constructs (70.5 kPa).
This work demonstrated that HAp was able to induce a
certain degree of chondrogenic differentiation as well, noting
upregulation in the expression of chondrogenic markers aggrecan
(ACAN) and Collagen Type II Alpha 1 Chain (COL2A1) from
FIGURE 5 | A summary of the most optimal current approach to 3D
bioprinting of cartilage structures. A structural support polymer (usually
synthetic) is chosen based on desired load-bearing capabilities and co-printed
with a range of biological polymers that provide elasticity and a growth
medium for seeded cells. Also included are stem cells capable of
differentiation into chondrocytes, and nano- (NPs) or microparticles (MPs)
encapsulating various growth factors (GFs) to induce differential differentiation
of stem cells and anti-inflammatory agents (AIs) to reduce post-implantation
inflammation. The release of GFs results in a gradual differentiation of seeded
stem cells into mature chondrocytes in a stratified manner. The resultant
construct has several key features that allows successful clinical translation.
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day 7 on, while levels of SRY-Box Transcription Factor 9 (SOX9)
were elevated considerably from day 14 on. The authors did not,
however, examine effects of the HAp on the construct’s
interaction with the subchondral bone, focusing instead on the
HAp’s ability to induce differentiation, provide strength/stiffness
and their ability to act as excellent surfaces for chondrocyte
growth and proliferation. In all, this integrative approach is
one that merits inclusion in more works in the field of
bioprinted cartilage.
The meniscus of the knee has also garnered the attention of 3D
bioprinting, mostly due to the inability of current techniques of
meniscus repair to address damage deeper in its structure (Guo
et al., 2021). Luo et al. (2020) described the design and
optimization of a bioink of gelatin, alginate and cellulose
nanofibers loaded with rabbit fibrochondrocytes (rFCs).
Several different formulations were tested, with pore size
increasing proportional to both gelatin and cellulose content:
low-gelatin alginate modified with cellulose nanofibers had pore
sizes of approximately 180 μm relative to the 300 μm observed in
high-gelatin alginate modified with cellulose. Their final
construct was printed based on translated MRI imaging data
and was thus patient-specific; it could maintain very high cell
viabilities (>90% over 14 days) and displayed markedly high
levels of collagen types II and X (Col II/X) in vitro. These are
both indicators of healthy cartilage, the latter being indicative of
the hypertrophic chondrocyte phenotype found deep in cartilage
structure.
The incorporation of growth factors (GFs) and other
molecules to initiate in situ differentiation of cells in
bioprinted cartilage constructs (as illustrated in Figure 5) has
been a growing area of interest. Several groups have published on
this topic in recent years, examining in various ways how GF can
influence cell-laden 3D bioprinted constructs (Henrionnet et al.,
2020; Chawla et al., 2021). This has provided an impetus for the
printing of constructs pre-loaded with GFs, in a major shift
towards biological biomimicry over simple mechanical or
morphological biomimicry. Sun et al. (2019) have been
frequent contributors to the area, with one of their earlier
works translating the findings of a genomics investigation into
a viable cartilage regeneration/replacement strategy using 3D
bioprinting. Having identified growth differentiation factor 5
(GDF5) as a chondroprotective agent capable of inducing
chondrogenic differentiation in rabbit BMSCs, they
encapsulated this agent within poly lactic-co-glycolic acid
(PLGA) microparticles (MPs) which were then printed into
the interfibrillar spaces of a PCL-based support structure,
alongside a composite hydrogel made of gelatin, fibrinogen,
hyaluronic acid and glycerol laden with rabbit BMSCs. More
than 80% of encapsulated GDF5 was observed to be released from
the microspheres within 60 days (in vitro), and cell proliferation
increased exponentially in vitro in the 21-day period tested. Most
notably, ultimate tensile strength (UTS) was very close to native
knee cartilage, as implants exhibited a UTS value of 24 MPa vs.
the physiological UTS of 28 MPa. In vivo, GDF5 laden constructs
were better able to produce hyaline-like neocartilage than
constructs without GDF5 MPs, alongside higher GAG and Col
II (also indicators of healthy native cartilage, and of chondrocyte
phenotype) and displayed better cell spreading and proliferation.
Continuing their work, the authors employed 3D bioprinting in
the construction of a goat meniscus using a similar approach as
above (Sun et al., 2021b). A hydrogel of the same type loaded with
goat BMSCs and PLGAMPs containing connective tissue growth
factor (CTGF) and (TGFβ3) were printed within a PCL scaffold.
Of interest were the conversion of imaging data of a goat
meniscus into a 3D model for the print and the differential
distribution of the MPs within the meniscus (CTGF-containing
MPs in the outer 1/3, TGFβ3 MPs in the inner 2/3) to stimulate
differential BMSC differentiation, an improvement upon the
indiscriminate differentiation in their previous work. Levels of
SOX9 were observed to be elevated by 2x (CTGF MPs) to 3.5x
(TGF β3 MPs) in vitro, relative to controls. Similar patterns of
GAG and Col II vs Col I in the inner- and outer layers were also
observed as in their previous work. In vivo, qualitative data
showed that goats implanted with the complete construct had
better 24-week mobility than those with control implants.
Histological analysis of the implanted menisci in that period
showed the expected native structure of an inner layer with an
abundance of Col I-expressing fibroblast-like cells and the outer
layer with Col II-expressing chondrocyte-like cells. Post-24 week
implants displayed mechanical properties nearly identical to
native cartilage, with statistically insignificant differences.
Ultimate tensile strength, for instance, stood at approximately
29 MPa in native cartilage vs. 28 MPa in the implants; overall
tensile modulus was higher in the implants by approximately
10 MPa. Radial and circumferential (both outer and inner layers)
tensile modulus readings showed that implants lagged behind
native cartilage by margins of less than 5%. By contrast, Deng
et al. employed human parathyroid hormone (PH) to prevent
chondrocyte hypertrophy in order to achieve and maintain
hyaline-like properties (Deng, 2021). They achieved this using
a biphasic, layered 3D bioprinted construct made of two distinct
bioinks. The first was a mix of GelMA and PH-conjugated SF
loaded with rabbit articular cartilage cells, while the second was a
mix of GelMA and methacrylated silk fibroin (MSF) loaded with
BMSCs, whose pore sizes ranged from 150 to 300 μm. The SF-
containing construct was shown to possess a compressive elastic
modulus of approximately 102.5 kPa vs. 211.1 kPa in the MSF-
containing constructs; compressive elastic strength was also
higher when MSF was present (260 kPa, a 4x increase over the
SF-containing constructs). Significantly lower levels of collagen X
and matrix metalloproteinase 13 (MMP13) were expressed by
cells grown in the complete construct relative to PH-negative
controls. PH was also successful in engendering higher levels of
Col II and ACAN in the cells, further confirming its role in
maintaining hyaline-like phenotype. In vivo, the complete
construct had filled lesions on rabbit knee cartilage by week
12 post-implantation. Yang et al. (2021) combined both GFs and
MSC-recruiting aptamers in an interesting novel approach.
Carbodiimide-mediated conjugation of HM69 aptamer was
carried out on decellularized ECM, which was in turn
dissolved in TGFβ3-containing GelMA. This bioink was then
co-printed with PCL to produce a layered, dual-functional lattice
structure with a heterogeneous macro- (800–1,000 μm) and
microporous (80–200 μm) structure. The compressive modulus
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of this material was observed to be approximately 25 kPa,
comparing favorably to expected in vivo physiological strain.
While cells were later externally cultured on these constructs,
what is of note was the ability of the HM69 to recruit adipose-
derived stem cells deeper into the construct both in vitro and in
vivo. These GF-loaded, bioprinted constructs are of great use to
this field as cell differentiation properties of printed constructs
remains paramount to the success of biomimetic cartilage
replacement/regeneration strategies. In particular, the inclusion
of GFs in extended release micro-/nanoformulations into 3D
bioprinted cartilage constructs circumvents a key stumbling block
these constructs face during clinical translation-namely, the lack
of long-term GF-based support once implanted (Francis et al.,
2018).
Recognizing the need for anisotropy for clinical translation,
Sun et al. (2020a) have also investigated the significance of
construct pore sizes on vascularization and oxidative stress
(which in turn influence cellular differentiation). Their design
was a four-layer 3D bioprinted construct with gradients of both
pore size and GFs. Using their BMSC-loaded, four-component
hydrogel within a PCL support referred to previously, the
construct was made such that the first layer was endowed with
a pore size of 150 μm, which steadily increased to 750 µm in the
final, innermost layer. This gradient was designed to
accommodate and encourage differentiation of rabbit BMSCs
into the smaller flattened chondrocytes observed in the superficial
zone of natural cartilage, then into the progressively larger
polymorphic- and columnar chondrocytes of the middle zone,
and finally, the hypertrophic chondrocytes of the deep zone. This
approach was supplemented with PLGA microparticles
encapsulating bone morphogenetic protein 4 (BMP4) in the
innermost layer of the construct and transforming growth
factor-β3 (TGFβ3) in the outermost/superficial one.
In vitro, a clear gradient in the expression of COL2A1 and
proteoglycan 4 (PRG4) (markers of the superficial zone of natural
cartilage) was observed, decreasing steadily from superficial to
deep layers (12x vs 1x for PRG4 and 9x vs 1x for COL2A1). Cells
in this region were observed to be fibroblast-like. Conversely, the
levels of Collagen Type X Alpha 1 Chain (COL10A1; cartilage
deep zone marker) were 9 times higher in the deep layer (relative
to superficial), resulting in clear chondrocyte hypertrophy. The
authors also managed to match physiological mechanical
properties (a Young’s modulus of approx. 300 MPa 12 weeks
post-implantation), maintain >70% cell viability in vitro and
confirm good functional capabilities/performance in vivo (with
consistently higher histological scores and virtually
indistinguishable integration with surrounding cartilage by
week 24, relative to single-GF controls. Better microvessel
ingrowth was also observed in the dual-GF constructs). These
so-called ‘dual stimuli’ constructs also fared better than controls
that either only had the pore size gradient alone or the growth
factor gradient alone. Yet another work by the same group
directed these anisotropic 3D bioprinting efforts at improving
their meniscus construct mentioned previously (Sun et al.,
2020b). Seeking again for better biomimicry, they repeated
their goat meniscus work within a rabbit model, this time with
the addition of microparticles carrying magnesium ions for
enhanced vascularization of the superficial zone and skeletal
muscle stem cells in place of BMSCs. Again, gradient cell
differentiation was recapitulated, and the neovascularization of
the superficial layer was observed to closely match the vascular
pattern observed in natural menisci (confirmed with endothelial
tube-forming assays, which showed the construct was highly
capable of inducing the same). In vivo, the constructs matched
natural cartilage in morphology, histological aspects, and
mechanical properties by week 24 (the latter being almost
identical to those seen in their earlier work). Anisotropy is a
key feature of natural systems and replicating this is especially
challenging in vitro. Nevertheless, these works discussed above
have shown how 3D bioprinting can overcome this issue, and
how established growth factor-loaded systems can be adapted for
such. Moreover, vascularization of tissue constructs (vital
particularly for menisci, which are naturally vascularized along
one facet) has long been a significant obstacle for clinical
translation of these technologies (Laschke and Menger, 2012;
Francis et al., 2018). The work last discussed in this section has
elegantly transcended this problem, combining anisotropy,
spatial control of cell/ink placement and controlled release of
GFs to set a benchmark for the field.
Cell-Based Bioprinting of Intervertebral
Discs
Damage to the cartilage of the intervertebral discs (IVDs) can be
particularly debilitating, given the key role the spine plays in
support and movement. Recapitulating–both biologically and
mechanically–the AF and NuP are important steps in
producing replacements or regeneration strategies for IVDs.
Composed of GAG and Col II, the NuP is a softer, elastic
tissue at the core of the IVD, helping distribute pressure
through it. The surrounding, harder AF is composed of
collagen type I (Col I), and acts as the tougher, load-bearing
and shape-maintaining portion of the IVD (Sun et al., 2021a).
Bioprinting efforts in this area (particularly in mimicking the AF)
have been stymied by the lack of dedicated bioinks for IVDs, as
others have already pointed out (Tavakoli et al., 2020). A notable
example of a novel bioink for IVDs was presented by Hu et al.,
who combined thermoplastics and hydrogels in a tunable, 3D
printed cartilage system using gellan gum-poly (ethylene glycol)
diacrylate (GG-PEGDA) and PLA (Wu et al., 2018). A dual-
nozzle printing mechanism formed an outer ring of PLA to
replicate the stiffer AF and GG-PEGDA hydrogels seeded with
murine bone marrow mesenchymal stem cells (BMSCs)
occupying the cavities of the PLA honeycomb substructure
standing in for the softer NuP. A Young’s modulus of 184 kPa
and a compressive strength of 55 kPa was observed in the final
construct. The near-total degradation of the PLA within
6 months, excellent cell viability (>90%, 7 days) within the
GG-PEGDA hydrogels and progressively high levels of F-actin
observed through immunostaining after 7 days (indicating good
cell spreading through the construct) were all signs that their
bioprinted structure would be a highly biomimetic IVD
replacement in vivo. Stevens et al. provides an overview of the
development of GG-based bioinks, while a recent review by Pieri
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et al. provide a more comprehensive review of possible novel
bioinks for IVD (Stevens et al., 2016; Pieri et al., 2020).
Notwithstanding advances in this field, truly biomimetic IVD
replacement/regeneration strategies are only beginning to be
researched. Two recent pieces of work stand out for being on
this cutting edge. Wu et al. (2021) recently outlined a PLA-based
scaffold printed parallelly alongside GG-PEGDA/rat BMSCs,
with the NuP and AF differentiated by the patterning of the
printed strands, aiming to mimic the porosity and mechanical
strength of the two. Of interest was the achievement of an
excellent, physiological Young’s modulus (remaining >8 MPa
over 14 days). When combined with the >80% in vitro cell
viability 2 weeks post-seeding, the maintenance of >75% disc
height in vivo over 6 months and comparable levels of
proteoglycan expression by the bioprinted implant as in the
case of reimplanted natural IVDs over the same period, this is
a clear sign that properly designed and -executed thermoplastic-
hydrogel composites still hold real promise in this area. The
authors did not, however, examine cellular differentiation along
their NuP-AF axis, crucial for true biomimicry. Sun et al. (2021a)
combined biomaterials, polymers, GFs, cells, and NPs in a
complex milieu to form a highly biomimetic IVD replacement
capable of inducing site-specific cell differentiation over time.
Their NuP consisted of their characteristic gelatin-sodium
alginate-hyaluronic acid hydrogel containing rat BMSCs and
polydopamine (PDA) NPs decorated with TGF-β3, while the
AF consisted of the same hydrogel with BMSCs, and PDA NPs
decorated with CTGF. Both were printed in a highly specific
pattern within a 3D printed PCL scaffold and capped with
cartilage endplates made of the same. Both GFs were found to
be released steadily over more than 30 days, while good cell
viability over this period in vitro predicted good differentiation
of BMSCs into AF- and NuP-specific tissue in vivo. Most notably,
these differentiations were observed to be clearly contained
within the envisioned NuP/AF divide, with cells in the NuP
portion expressing significantly higher GAG/Col II than those in
the AF, and cells in the AF expressing higher Col I levels relative
to those in the NuP. While the mechanical properties were not
ideal (approaching, but not closely matching physiological
compressive modulus), this is cause for excitement in this
nascent field, showing how in situ differentiation along with
the spatial control offered by 3D bioprinting can achieve
remarkably biomimetic results.
One notable drawback of the cartilage constructs described
so far is a phenomenon the authors themselves have
highlighted- 3D bioprinted constructs, no matter how
biomimetic, tend to elicit an immune response post-
implantation that may last for weeks. Several recent works
have outlined bioprinting strategies to solve this problem,
albeit based more on traditional 3D printing supplemented
with later cell seeding rather than direct bioprinting (Sun et al.,
2019; 2020a). Zhu et al. (2020) described a PEGDA and
decellularized ECM composite cartilage construct loaded
with a natural anti-inflammatory agent (honokiol; 3′,5-Di
(prop-2-en-1-yl)[1,1′-biphenyl]-2,4′-diol). This was
observed to suppress the release of pro-inflammatory
cytokines including TNF-α, IL-1β and IL-6 in vitro (by
approximately 2.5x, 3x, and 2x, respectively, all matching
non-inflamed controls except in the case of IL-6). While
levels of inflammation were not measured in vivo post-
implantation, the use of mild natural compounds may
certainly be helpful in forming bioprinted constructs that
can manage inflammation without stressing the seeded cells.
Lee et al. (2019) outlined a possible role for curcumin in
bioprinted cartilage constructs (viz. a gelatin-curcumin
bioink) but did not elaborate on any anti-inflammatory
properties observed in their work. Indeed, natural anti-
inflammatory, analgesic compounds such as curcumin,
gingerol, resveratrol and others hold much promise in this
area- Buhrmann et al. (2020) provide a good recent review of
these compounds and their myriad benefits in the context of
cartilage tissue engineering in particular. Gong et al. (2020) too
presented a method wherein anti-inflammatory IL-4 was
printed into a GelMA hydrogel/PCL-hydroxyapatite support
to achieve lower immune responses in their cartilage
regeneration model. In vivo, they observed success in the
form of higher histological scores and qualitatively better
chondrocyte development post-implantation in the IL-4
loaded constructs compared to controls. This incorporation
of anti-inflammatories–while not essential–is a relatively
under-researched area in the field, and advances in this area
will enhance clinical translation immensely. Figure 5 provides
a summary and most optimal approach to cartilage bioprinting
discussed herein.
FUTURE OUTLOOK
3D bioprinting is a fast-moving field, and applications of this
technology stand to benefit from this rapid pace of
advancement. A recent development of interest is
Samandari et al. report of multicompartmental bioprinting
and its ability to successfully orient cells during printing
(Samandari, 2021). The bioprinting of cartilage stands to
gain from technologies such as this, as the spatial
orientation of chondrocytes in constructs plays a significant
role in in vitro and -vivo success. However, the need for such
developments to be complemented by advances in polymer
science and more significant contributions from nano- and
microscale engineering must be recognized.
There is still much work to be done in the identification of
polymer blends that accurately mimic the mechanical
properties and biomechanics of natural cartilage, as well as
blends that provide high load-bearing and wear-resistant
capabilities. As menisci are responsible for stabilizing
joints and acting as shock absorbers, mechanical properties
remain one of the most important characteristics to consider
when designing appropriate implants for meniscal repairs
(Inyang and Vaughan, 2020). This is also of particular
concern for IVDs, which differ in anatomy and function
by location in the spinal column. For instance, in flexion
and extension of the lumbar spine, anterior translation of one
vertebra or the other should be 8% or less, while posterior
translation should be 9% or less. Translation exceeding this is
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known as alteration of motion segment integrity (AOMSI).
Additionally, angular motion of one lumbar vertebra to
adjacent vertebra should allow no greater than 15 degrees
difference within the first three lumbar units, L1/L2, L2/L3, or
L3/L4 or no more than 20 degrees at L4/L5 and 25 degrees at
L5/S1 (Keeney, 1984). This is a level of complexity that the
field cannot yet achieve but must aim for eventually and must
mostly be addressed using polymer science. Further, it has
been demonstrated that mechanical properties, as well as
mesh size (both of which can be impacted by polymer
molecular weight) play a key role in modulating the
viability and proliferation of chondrocyte-laden constructs
(Lin et al., 2011). In addition, several studies have shown that
modifications in polymer surface nanotopography
(i.e., surface roughness) can lead to increased chondrocyte
density and protein production due to enhanced protein
binding on micro- and nano-rough surfaces (Storey and
Webster, 2014). Advances in anti-inflammatory polymers
or polymeric coatings may be of great use to this field as
well-this is an active area of research for surgical implants in
general, reviewed recently by both Sánchez-Bodón et al. and
Lebaudy et al (Bridges and García, 2008; Al-Khoury et al.,
2019; Lebaudy et al., 2021; Sánchez-Bodón et al., 2021).
Recent work in this field has also evolved to incorporate
decellularized extracellular matrix (dECM) from cartilage
and IVD into 3D-printable bioinks to aid in guiding cell
proliferation, attachment, and differentiation (Vernengo
et al., 2020). For example, Kesti et al. (2015) developed a
novel composite bioink comprised of gellan and alginate
containing micronized BioCartilage, a commercially
available extracellular matrix material native to articular
cartilage, which supported chondrocyte proliferation and a
favorable deposition of cartilage matrix proteins. While this
particular bioink was developed for a broad range of tissue
engineering applications, advancements like these may serve
as a stepping-stone for the development of more finely-tuned
bioinks to better address deficiencies in knee menisci and
IVD repair strategies. The factors outlined above must all be
considered when developing novel bioink formulations for
this area of research.
Slow-release nano- or microformulations encapsulating
growth factors and other signaling molecules to encourage
proper cell differentiation, or those encapsulating agents such
as anti-inflammatories or even anti-microbials to enhance post-
implantation success are also of great interest to the field. Novel
dual-action molecules tailored for cartilage repair like REG-O3
may be of interest to future researchers in this regard (Montjean
et al., 2020). A possible way to integrate all this with traditional
bioprinting may be to involve nano- or microscale fibers, such as
carbon nanotubes (CNTs), that can lend structural support to
constructs as well as releasing such agents from their core or their
surface. Szymański (2020) provide an excellent review of recent
tissue engineering work that has involved CNTs. Capable of self-
assembly into nanostructures and acting as cell adhesion points
or growth factor binding sites, peptide amphiphiles are also
possible additives to cartilage bioinks that are already being
explored in other tissue engineering approaches (Lewis et al.,
2020; Di Marzio et al., 2020). The next wave of bioink
development should also most certainly focus on biomaterials
that exhibit 4D bioprinting properties, consisting of materials that
can be 3D printed, yet also respond to environmental stimuli (e.g.,
temperature, pH, etc.) over a desired duration of time (Saska et al.,
2021). For example, Betsch et al. (2018) developed a magnetically
responsive iron nanoparticle-based bioink capable of producing
constructs exhibiting alternating layers of aligned and random
collagen fibers able to more accurately recapitulate the complex
architecture of native articular cartilage, leading to enhanced
collagen II production. Multilayered nano-/microparticles or
-fibers can lend additional complexity to cartilage bioprinting
by effecting fine control of chondrocyte differentiation and
growth through temporally-controlled release of growth factors
and other signaling molecules (Go et al., 2011; Asiri et al., 2021).
Despite the availability of a considerable body of non-human in
vivo data, 3D bioprinted cartilage constructs have–so far–not
moved on to clinical trials. While fundamental research paves the
way to more advanced applications, a field as nascent as this will
eventually require clinical data for the refinement and evolution
of the field, identifying shortcomings that exist in the in vitro
development process that impact downstream clinical
translation. In this light, it is heartening to note that such
trials are now almost underway, with 3DBio Therapeutics’
AuriNovo technology (3D bioprinted auricular cartilage for
microtia) on the verge of recruiting trial subjects
(NCT04399239). The technology is based on a proprietary
bioink containing patient-derived (autologous) chondrocytes
(AuriNovo for Auricular Reconstruction, 2020). This
technology has been spurred in part by the introduction of
personalized medicine to this field-a development rooted in
the problem of possible implant rejection in a clinical setting
as discussed earlier, and the autologous approaches needed to
overcome it (Edri et al., 2019).
The need for printed constructs to encourage proper
differentiation of seeded stem cells in the correct spatial
orientation and patterning is another area that merits further
investigation. The majority of works discussed in this review have
opted for a static pore size, for instance. While there is evidence in
literature that pore sizes of 100–300 μm are optimal for cell
differentiation and orientation within constructs, anisotropy in
both this and in the release of growth factors, anti-inflammatory
agents, anti-microbials etc. from nano/microparticles or -fibers
may provide exciting new avenues of producing constructs that
are more physiologically relevant, particularly when combined.
This is highlighted by Sun and others’ work (Zhang et al., 2014;
Han et al., 2015; Naseri et al., 2016; Song et al., 2017; Sun et al.,
2020a).
As tissue constructs go, cartilage has a relatively simple and
straightforward structure to attempt to mimic than many other
tissues in the human body. A successful convergence of new
and improved polymers, precise bioprinting techniques
focusing on anisotropy and dedicated “regions” of cartilage
structure, optimized additives, and translation-friendly cell
isolation, all complemented with regular feedback in the
form of clinical data will define the direction this promising
technology will take in the coming years.
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